Heparan sulfate proteoglycans and cancer (original) (raw)
References
Alexander CM, Reichsman F, Hinkes MT, Lincecum J, Becker KA, Cumberledge S and Bernfield M (2000) Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet25: 329–332 ArticleCASPubMed Google Scholar
Arai T, Akiyama Y, Nagasaki H, Murase N, Okabe S, Ikeuchi T, Saito K, Iwai T and Yuasa Y (1999) EXTL3/EXTR1 alterations in colorectal cancer cell lines. Int J Oncol15: 915–919 CASPubMed Google Scholar
Aviezer D, Iozzo RV, Noonan DM and Yayon A (1997) Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA. Mol Cell Biol17: 1938–1946 ArticleCASPubMedPubMed Central Google Scholar
Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J and Zako M (1999) Functions of cell surface heparan sulphate proteoglycans. Ann Rev Biochem68: 719–777 Article Google Scholar
Chang Z, Meyer K, Rapraeger A and Friedl A (2000) Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ. FASEB J14: 137–144 ArticleCASPubMed Google Scholar
Choi C, Cho S, Horikawa I, Berchuck A, Wang N, Cedrone E, Jhung SW, Lee JB, Kerr J, Chenevix-Trench G, Kim S, Barrett JC and Koi M (1997) Loss of heterozygosity at chromosome segment Xq25–26.1 in advanced human ovarian carcinomas. Genes Chromosomes Cancer20: 234–242 ArticleCASPubMed Google Scholar
Conejo JR, Kleeff J, Koliopanos A, Matsuda K, Zhu ZW, Goecke H, Bicheng N, Zimmermann A, Korc M, Friess H and Buchler MW (2000) Syndecan-1 expression is up-regulated in panceatic but not in other gastrointestinal cancers. Int J Cancer88: 12–20 ArticleCASPubMed Google Scholar
Dhodapkar MV, Abe E, Theus A, Lacy M, Langford JK, Barlogie B and Sanderson RD (1998) Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation. Blood91: 2679–88
Esko J (1999) Genetic analysis of proteoglycan structure, function and assembly. In Cell Surface Proteoglycans in Signalling and Development, Lander A, Nakato H, Selleck SB, Turnbull JE, Coath C (ed) pp 35–40, HFSP: Strasbourg Google Scholar
Gallagher JT and Lyon M (2000) Heparan sulphate: Molecular structure and interactions with growth factors and morphogens. In: Proteoglycans: Structure, Biology and Molecular Interactions, (Ed. Iozzo RV) Marcel Dekker: New York Google Scholar
Gonzalez AD, Kaya M, Shi W, Song H, Testa JR, Penn LZ and Filmus J (1998) OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. J Cell Biol141: 1407–1414 ArticleCASPubMedPubMed Central Google Scholar
Hecht JT, Hogue D, Strong LC, Hansen MF, Blanton SH and Wagner M (1995) Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome 11 and loss of heterozygosity for EXT-linked markers on chromosomes 11 and 8. Am J Hum Genet56: 1125–1131 CASPubMedPubMed Central Google Scholar
Hirabayashi K, Numa F, Suminami Y, Murakami A, Murakami T and Kato H (1998) Altered proliferative and metastatic potential associated with increased expression of syndecan 1. Tumour Biol19: 454–463 ArticleCASPubMed Google Scholar
Jayson GC, Lyon M, Paraskeva C, Turnbull JE, Deakin JA and Gallagher JT (1998) Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J Biol Chem273: 51–7
Kitagawa H, Shimakawa H and Sugahara K (1999) The tumor suppressor EXT-like gene EXTL2 encodes an α1, 4-N-Acetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-Acetylglucosamine to the common glycosaminoglycan-protein linkage region. J Biol Chem274: 13933–13937 ArticleCASPubMed Google Scholar
Kleef J, Ishiwata T, Kumbasar A, Friess H, Buchler MW, Lander AD and Korc M (1998) The cell-surface heparan sulphate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest102: 1662–1673 Article Google Scholar
Kumar-Singh S, Jacobs W, Dhaene K, Weyn B, Bogers J, Weyler J and Van Marck E (1998) Syndecan-1 expression in malignant mesothelioma: corrlelation with cell differentiation, WT1 expression, and clinical outcome. J Pathol186: 300–305 ArticleCASPubMed Google Scholar
Lin H, Huber R, Schlessinger D and Morin PJ (1999) Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res59: 807–810 CASPubMed Google Scholar
Lind T, Tufaro F, McCormick C, Lindahl U and Lidholt K (1998) The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem273: 26265–26268 ArticleCASPubMed Google Scholar
Lindahl U, Kusche-Gullberg M and Kjellen L (1998) Regulated diversity of heparan sulfate. J Biol Chem273: 24979–82
Matsumoto A, Ono M, Fujimoto Y, Gallo L, Bernfield M and Kohgo Y (1997) Reduced expression of Syndecan 1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer74: 482–491 ArticleCASPubMed Google Scholar
McCormick C, Leduc Y, Martindale D, Mattison K, Esford LE, Dyer AP and Tufaro F (1998) The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat Genet19: 158–161 ArticleCASPubMed Google Scholar
McKenzie E, Tyson K, Stamps A, Smith P, Turner P, Barry R, Hircock M, Patel S, Barry E, Stubberfield C, Terrett J and Page M (2000) Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun276: 1170–1177 ArticleCASPubMed Google Scholar
Merry CL, Lyon M, Deakin JA, Hopwood JJ and Gallagher JT (1999) Highly-sensitive sequencing of the sulphated domains of heparan sulphate. J Biol Chem274: 18455–18462 ArticleCASPubMed Google Scholar
Murthy SS, Shen T, De Rienzo A, Lee W-C, Ferriola PC, Jhanwar SC, Mossman BT, Filmus J and Testa JR (2000) Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Oncogene19: 410–416 ArticleCASPubMed Google Scholar
Nackaerts K, Verbeken E, Deneffe G, Vanderschueren B, Demedts M and David G (1997) Heparan sulphate proteoglycan expression in human lung cells. Int J Cancer74: 335–345 ArticleCASPubMed Google Scholar
Paine-Saunders S, Viviano BL, Zupich J, Skarnes WC and Saunders S (2000) Glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development. Dev Biol225: 179–187 ArticleCASPubMed Google Scholar
Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A and Schlessinger D (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi -Behmel overgrowth syndrome. Nat Genet12: 241–247 ArticleCASPubMed Google Scholar
Pye DA, Vives RR, Turnbull JT, Hyde P and Gallagher JT (1998) Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J Biol Chem273: 22936–22942 ArticleCASPubMed Google Scholar
Raskind WH, Conrad EU, Chansky H and Matsushita M (1995) Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11. Am J Hum Genet56: 1132–1139 CASPubMedPubMed Central Google Scholar
Seidel C, Sundan A, Hjorth M, Turesson I, Dahl IM, Abildgaard N, Waage A and Borset M (2000) Serum syndecan-1: a new independent prognostic marker in multiple myeloma. Blood95: 388–92
Selleck SB (2000) Proteoglycans and pattern formation – Sugar biochemistry meets developmental genetics. Trends Genet16: 206–212 ArticleCASPubMed Google Scholar
Sharma B, Handler M, Eichstetter I, Whitelock JM, Nugent MA and Iozzo RV (1998) Antisense targetting of perlecan blocks tumor growth and angiogenesis in vivo. J Clin Invest102: 1599–1608 ArticleCASPubMedPubMed Central Google Scholar
Stanley MJ, Stanley MW, Sanderson RD and Zera R (1999) Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. Am J Clin Pathol112: 377–383 ArticleCASPubMed Google Scholar
Stickens D, Brown D and Evans G (2000) EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis. Dev Dyn218: 452–464 ArticleCASPubMed Google Scholar
Van Kuppevelt TH, Dennissen MABA, van Venrooij WJ, Hoet RMA and Veerkamp JH (1998) Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. J Biol Chem273: 12960–12966 ArticleCASPubMed Google Scholar
Veugelers M, Cat BD, Muyldermans SY, Reekmans G, Delande N, Frints S, Legine E, Fryns JP, Schrander-Stumpel C, Weidle B, Magdalena N and David G (2000) Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Hum Mol Genet9: 1321–8
Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L and Pecker I (1999) Mammalian heparanse: Gene cloning, expression and function in tumor progression and metastasis. Nat Med5: 793–802 ArticleCASPubMed Google Scholar